ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,672Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 18

$567K Total Retail Price of All Prescriptions

Rank: 4 out of 18

391 Patients Receiving at Least One Drug in Part D
94% Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Rhode Island
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

12% of this provider’s 391 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

8% of this provider’s 391 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 33.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
WARFARIN SODIUM 928 923* 46 1 1
FUROSEMIDE 566 561* 72 2 2
LEVOTHYROXINE SODIUM 560 548 66 3 4
LISINOPRIL 523 497 68 4 3
SERTRALINE HCL 425 364 43 5 10
AMLODIPINE BESYLATE 404 392 58 6 5
METOPROLOL TARTRATE 365 360* 59 7 8
ATORVASTATIN CALCIUM 307 302* 46 8 9
DONEPEZIL HCL 300 295* 46 9 12
NAMENDA 291 291 31 10 13
MIRTAZAPINE 278 263 45 11 14
TRAZODONE HCL 261 237 52 12 11
HYDROCHLOROTHIAZIDE 251 251 45 13 15
OMEPRAZOLE 247 242* 42 14 6
SIMVASTATIN 233 228* 45 15 7
CITALOPRAM HBR 197 171 32 16 16
HYDROCODONE-ACETAMINOPHEN 177 162 31 S3 17 20
ESCITALOPRAM OXALATE 177 177 25 17 29
METOPROLOL SUCCINATE 174 174 28 19 21
GLIPIZIDE 154 149* 21 20 39
ALLOPURINOL 143 143 19 21 31
HYDRALAZINE HCL 142 137* 20 22 68
LOSARTAN POTASSIUM 122 122 21 23 24
CLOPIDOGREL 106 101* 16 24 23
ATENOLOL 104 92 20 25 22
QUETIAPINE FUMARATE 100 100 18 A 26 18
GABAPENTIN 98 78 24 27 17
METFORMIN HCL 92 77 21 28 19
ALENDRONATE SODIUM 84 84 14 29 34
DIOVAN 83 83 11 30 32
POLYETHYLENE GLYCOL 3350 82 77* 22 31 25
ALBUTEROL SULFATE 81 76* 20 32 97
ZETIA 78 <11 <11 33 66
RISPERIDONE 75 <11 <11 A 34 55
LACTULOSE 73 <11 <11 35 66
GLIPIZIDE ER 72 <11 <11 36 70
LATANOPROST 71 66* 14 37 50
LANTUS 69 64* 12 38 34
TAMSULOSIN HCL 68 68 11 39 27
ENALAPRIL MALEATE 68 63* 14 39 58
PRAVASTATIN SODIUM 68 63* 11 39 26
NIASPAN 67 <11 <11 42 116
LOVASTATIN 67 <11 <11 42 56
LIDODERM 64 53 12 44 48
DILTIAZEM 24HR CD 62 <11 <11 45 77
OLANZAPINE 62 <11 <11 A 45 54
SPIRIVA 60 55* 13 47 37
BRIMONIDINE TARTRATE 59 <11 <11 48 99
VENLAFAXINE HCL ER 56 <11 <11 49 36
TIMOLOL MALEATE 56 <11 <11 49 101
CIPROFLOXACIN HCL 53 48* 30 51 95
CLOTRIMAZOLE-BETAMETHASONE 52 <11 <11 52 176
DIGOXIN 51 <11 <11 53 97
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 26, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.